Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: Metered dose inhaler versus jet nebulizer

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 13, Issue 1, 2000, Pages 25-33

  Balzano, Giovanni ^a   Battiloro, Raimondo ^a   Biraghi, Maurizio ^b   Stefanelli, Francesco ^a   Fuschillo, Salvatore ^a   Gaudiosi, Carlo ^a   De Angelis, Emilio ^a  

^a IRCCS   (Italy)

^b Valeas SpA   (Italy)

Author keywords

Aerosol therapy; Airflow obstruction; Asthma; COPD; Jet nebulizer; MDI; Reversibility of airway obstruction

Indexed keywords

FLUNISOLIDE; IPRATROPIUM BROMIDE; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; NEBULIZER; PRESCRIPTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0034120751     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2000.13.25     Document Type: Conference Paper

References (31)

1. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152(suppl):S77-S120.
2. Siafakas, N.M., P. Vermeire, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, J.C. Yernault, M. Decramer, T. Higenbottam, D.S. Postma, and J. Rees, on behalf of the European Respiratory Society Task Force. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). ERS-consensus statement. Eur. Respir. J. 8:1398-1420.
3. British Thoracic Society. 1997. BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax. 52(Suppl 5):S1-S28.
4. Sheffer, A.L. 1995. Global strategy for asthma management and prevention. Publication No. 95-3659. National Institutes of Health. National Heart, Lung, and Blood Institute, Bethesda, MD.
5. Guidelines for the Diagnosis and Management of Asthma. 1997. Publication No. 97-4051. National Institutes of Health. National Heart, Lung, and Blood Institute, Bethesda, MD.
6. British Thoracic Society. 1997. The British guidelines on asthma management. Review and position statement. Thorax. 52(Suppl 1):S1-S21.
7. Vaswani, S.K., and P.S. Creticos. 1998. Metered dose inhaler: Past, present, and future. Ann. Allergy Asthma Immunol. 80:11-21.
8. Newhouse, M.T., and M.B. Dolovich. 1986. Control of asthma by aerosol. N. Engl. J. Med. 315:870-874.
9. Newhouse, M.T. 1991. Advantages of pressurizedcanister metered-dose inhalers. J. Aerosol. Med. 3:139-150.
10. Crompton, G.K. 1982. Problems patients have using pressurized aerosol inhalers. Eur. J. Respir. Dis. 63 (Suppl 119):101-104.
11. Zanon, P. 1994. Inhalation antiasthma therapy with spacers: Technical aspects. Monaldi Arch. Chest Dis. 49: 258-264.
12. Schecker, M.H., A.F. Wilson, D.S. Mukai, H. Hahn, D. Crook, and H.S. Novey. 1993. A device for overcoming disco-ordination with metered-dose inhalers. J. Allergy Clin. Immunol. 92:783-789.
13. Crompton, G.K. 1982. Clinical use of dry powder systems. Eur. J. Respir. Dis. 63:96-98.
14. Melillo, E., and G. Balzano. 1996. Drugs by inhalatory route: An overview and upcoming clinical perspectives. Monaldi Arch. Chest Dis. 51:405-412.
15. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with COPD and asthma. Am. Rev. Respir. Dis. 136:225-244.
16. De Blaquiere, P., D.B. Christensen, W.B. Carter, and T.R. Hartin. 1989. Use and misuse of metered-dose inhaler by patients with chronic lung disease. Am. Rev. Respir. Dis. 140:910-916.
17. American Thoracic Society. 1987. Standardization of spirometry: 1987-update. Am. Rev. Respir. Dis. 136: 1285-1298.
18. Weber, R.W., W.E. Petty, and H.S. Nelson. 1979. Aerosolized terbutaline in asthmatics. Comparison of dosage strength, schedule, and method of administration. J. Allergy Clin. Immunol. 63:116-121.
19. Christensson, P., M. Arborelius, and B. Lilja. 1981. Salbutamol inhalation in chronic bronchial asthma: Dose aerosol vs jet nebulizer. Chest. 79:416-419.
20. Cushley, M.J., R.A. Lewis, and A.E. Tattersfield. 1993. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax. 38:908-913.
21. Harrison, B.A., and R.J. Pierce. 1983. Comparison of wet and dry aerosol salbutamol. Aust. N. Z. J. Med. 13:29-33.
22. Jasper, A., Z. Mohsenifar, S. Kahan, H.S. Goldberg, and S.K. Koerner. 1987. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest. 91:614-618.
23. Turner, J.R., K.J. Corkery, D. Eckman, A.M. Gelb, A. Lipavsky, and D. Sheppard. 1988. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest. 93:476-481.
24. Campbell, I.A., S.B. Colman, J.H. Mao, R.J. Prescott, and C.F.M. Weston. 1995. An open, prospective comparison of β2-agonist given via nebuliser, Nebuhaler, or pressurized inhaler by ambulance crew as emergency treatment. Thorax. 50:79-80.
25. Raimondi, A.C., J. Schottlender, D. Lombardi, and N.A. Molfino. 1997. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest. 112:24-28.
26. Mandelberg, A., E. Chez, N. Noviski, and I.E. Priel. 1997. Nebulized wet aerosol treatment in emergency department-is it essential? Comparison with large spacer device for metered-dose inhaler. Chest. 112: 1501-1505.
27. Wilson, R.S.E., and S.J. Connellan. 1980. Domiciliary nebulized salbutamol solution in severe chronic airway obstruction. Thorax. 35:873-876.
28. Olivenstein, R., N. Wolkove, C. Cohen, H. Frank, and H. Kreisman. 1986. A comparison of responses to albuterol delivered by two aerosol devices. Chest. 90:392-395.
29. Jenkins, S., R.W. Heaton, T.J. Fulton, and J. Moxham. 1987. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest. 91:804-807.
30. Mestitz, H., J.M. Copland, and C.F. McDonald. 1989. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest. 96:1237-1240.
31. Corden, Z.M., M. Bosley, P.J. Rees, and G. McLellan Cochrane. 1997. Home nebulized therapy for patients with COPD. Patient compliance with treatment and its relation to quality of life. Chest. 112:1278-1282.